NITOMAN

This brand name is authorized in Canada, Spain, Ireland

Active ingredients

The drug NITOMAN contains one active pharmaceutical ingredient (API):

1 Tetrabenazine UNII Z9O08YRN8O - TETRABENAZINE

Tetrabenazine is a synthetic derivative of benzylquinolizine that causes depletion of dopamine and other monoamines in the central nervous system. The precise mechanism by which tetrabenazine exerts its effects is unknown, but is believed to be related to its effect as a reversible depletor of monoamines (such as dopamine, serotonin, norepinephrine, and histamine) from nerve terminals. Neurotransmitter depletion by a single dose of tetrabenazine is reversible and lasts only a few hours. Read about Tetrabenazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NITOMAN Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX06	Tetrabenazine	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02199270
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70142
Country: IE	Health Products Regulatory Authority	Identifier(s): 36524